No. 24A720

Merck Sharp & Dohme Corporation v. Doris Albrecht, et al.

Lower Court: Third Circuit
Docketed: 2025-01-22
Status: Presumed Complete
Type: A
Experienced Counsel
Tags: drug-labeling failure-to-warn federal-regulations pharmaceutical-liability preemption product-liability
Latest Conference: N/A
Question Presented (AI Summary)

Whether federal preemption principles under the Wyeth v. Levine framework preclude state law failure-to-warn claims against pharmaceutical manufacturers when federal drug labeling requirements are at issue

Docket Entries

2025-01-24
Application (24A720) granted by Justice Alito extending the time to file until March 19, 2025.
2025-01-16
Application (24A720) to extend the time to file a petition for a writ of certiorari from February 17, 2025 to March 19, 2025, submitted to Justice Alito.
Main DocumentLower Court Orders/OpinionsLower Court Orders/OpinionsProof of ServiceMain DocumentLower Court Orders/OpinionsLower Court Orders/OpinionsProof of Service

Attorneys

Merck Sharp & Dohme Corporation
Jacob Moshe Roth — Jones Day, Petitioner
Jacob Moshe Roth — Jones Day, Petitioner